Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial.


Benn, CS; Fisker, AB; Napirna, BM; Roth, A; Diness, BR; Lausch, KR; Ravn, H; Yazdanbakhsh, M; Rodrigues, A; Whittle, H; Aaby, P; (2010) Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ (Clinical research ed), 340. c1101. ISSN 0959-8138 DOI: 10.1136/bmj.c1101

[img]
Preview
Text - Published Version
License:

Download (169kB) | Preview

Abstract

OBJECTIVE To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. DESIGN Randomised, placebo controlled, two by two factorial trial. SETTING Bissau, Guinea-Bissau. PARTICIPANTS 1717 low birthweight neonates born at the national hospital. INTERVENTION Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months. MAIN OUTCOME MEASURE Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo. RESULTS No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to "early BCG" versus "no early BCG" was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex). CONCLUSIONS The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre: Vaccine Centre
PubMed ID: 20215360
Web of Science ID: 275656700001
URI: http://researchonline.lshtm.ac.uk/id/eprint/311005

Statistics


Download activity - last 12 months
Downloads since deposit
306Downloads
318Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item